Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells

Worldwide, the number of cancer-related deaths continues to increase due to the ability of cancer cells to become chemotherapy-resistant and metastasize. For women with ovarian cancer, a staggering 70% will become resistant to the front-line therapy, cisplatin. Although many mechanisms of cisplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabelo-Fernández, Robert J., Santiago-Sánchez, Ginette S., Sharma, Rohit K., Roche-Lima, Abiel, Carrion, Kelvin Carrasquillo, Rivera, Ricardo A. Noriega, Quiñones-Díaz, Blanca I., Rajasekaran, Swetha, Siddiqui, Jalal, Miles, Wayne, Rivera, Yasmarie Santana, Valiyeva, Fatima, Vivas-Mejia, Pablo E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745614/
https://www.ncbi.nlm.nih.gov/pubmed/35008958
http://dx.doi.org/10.3390/ijms23010535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745614/
https://www.ncbi.nlm.nih.gov/pubmed/35008958
http://dx.doi.org/10.3390/ijms23010535

Ejemplares similares